Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Survodutide for treatment of obesity: baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1)
le Roux CW, Wharton S, Bozkurt B, et al.
Diabetes Obes Metab. Pub. online 4 Nov 2025.
Leggi
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
Billings LK, Hsia S, Bays H, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Percorso Executive di alta formazione in Digital and Future Health: AMD – Politecnico di Milano
Carissimi Soci, è stato ufficialmente avviato il percorso Executive di Alta Formazione in Digital and Future Health: nuove competenze e expertise per il diabetologo digitale. Il primo appuntamento di questo progetto altamente innovativo si è tenuto negli scorsi giorni, in modalità residenziale, presso il Campus Bovisa del Politecnico di Milano. I 35 diabetologi selezionati si sono confrontati…
Leggi
Social determinants of health and cancer prevention guideline behaviors
Chiang KE, Padilla HM, Callands TA, et al.
JAMA Netw Open. Pub. online 3 Nov 2025.
Leggi
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
Gitelman SE, Simmons K, Sherr JL, et al.
Diabetologia. Pub. online 6 Nov 2025.
Leggi
Synergistic associations of metformin and GLP-1 receptor agonist use with adiposity-related cancer incidence in people living with type 2 diabetes
Henney AE, Heague M, Riley DR, et al.
Diabetes Obes Metab. Pub. online 3 Nov 2025.
Leggi
Role of circadian health in cardiometabolic health and disease risk: a scientific statement from the American Heart Association
Knutson KL, Dixon DD, Grandner MA, et al.
Circulation. Pub. online 28 Oct 2025.
Leggi
Screening natriuretic peptide levels predicts heart failure and death in individuals with type 1 and type 2 diabetes without known heart failure
Pop-Busui R, Repetto E, Baron J, et al.
Diabetes Care. Pub. online 30 Oct 2025.
Leggi